Anthony G. Viscogliosi co-founded Viscogliosi Brothers, LLC (VB) along with his two brothers, John and Marc. He has founded or been involved in operations and strategy of more than 20 companies and investment funds in the neuro-musculoskeletal/orthopedic industry. He serves or served as chairman, executive chairman, CEO, president, managing director, or managing member of more than 15 businesses. VB, its funds, or affiliates have invested in companies that have sold for more than $1.5 billion in exit proceeds in the last 17 years. Mr. Viscogliosi has participated in raising more than $500 million in capital for businesses in the orthopedic industry. He is the CEO of Aperion Biologics, Inc., the leading regenerative medicine focused ACL replacement company globally.